A randomized, placebo-controlled phase 2 trial of subcutaneous interleukin-1 receptor antagonist in acute ischaemic stroke

Activity: Talk or presentationOral presentationResearch

Period17 May 2017
Event title3rd European Stroke Organisation Conference
Event typeConference
LocationCzech RepublicShow on map
Degree of RecognitionInternational


  • Acute ischaemic stroke; interleukin-1; interleukin-1 receptor antagonist

Research Beacons, Institutes and Platforms

  • Lydia Becker Institute